In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Jasper Therapeutics Inc (NASDAQ: JSPR) closed the day trading at $1.65 up 4.43% from the previous closing price of $1.58. In other words, the price has increased by $4.43 from its previous closing price. On the day, 3.77 million shares were traded. JSPR stock price reached its highest trading level at $1.66 during the session, while it also had its lowest trading level at $1.39.
Ratios:
For a better understanding of JSPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.59 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 22 ’25 when WIGGANS THOMAS G bought 41,000 shares for $2.43 per share. The transaction valued at 99,630 led to the insider holds 41,000 shares of the business.
Lucas Svetlana bought 20,000 shares of JSPR for $48,600 on Sep 22 ’25. The Director now owns 20,000 shares after completing the transaction at $2.43 per share. On Sep 22 ’25, another insider, MARTELL RON, who serves as the President and CEO of the company, bought 41,000 shares for $2.43 each. As a result, the insider paid 99,630 and bolstered with 74,118 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JSPR now has a Market Capitalization of 46173664 and an Enterprise Value of -3022335.
Stock Price History:
The Beta on a monthly basis for JSPR is 3.09, which has changed by -0.92661405 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, JSPR has reached a high of $26.05, while it has fallen to a 52-week low of $1.55. The 50-Day Moving Average of the stock is -22.50%, while the 200-Day Moving Average is calculated to be -56.02%.
Shares Statistics:
Over the past 3-months, JSPR traded about 1.34M shares per day on average, while over the past 10 days, JSPR traded about 6452970 shares per day. A total of 27.98M shares are outstanding, with a floating share count of 24.26M. Insiders hold about 13.29% of the company’s shares, while institutions hold 59.97% stake in the company. Shares short for JSPR as of 1763078400 were 1508904 with a Short Ratio of 1.12, compared to 1760486400 on 1547641. Therefore, it implies a Short% of Shares Outstanding of 1508904 and a Short% of Float of 5.43.
Earnings Estimates
The performance of Jasper Therapeutics Inc (JSPR) in the stock market is under the watchful eye of 3.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.68, with high estimates of -$0.56 and low estimates of -$0.79.
Analysts are recommending an EPS of between -$4.07 and -$5.67 for the fiscal current year, implying an average EPS of -$5.02. EPS for the following year is -$3.29, with 6.0 analysts recommending between -$1.34 and -$4.91.
